Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Phelps

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Science Translational Medicine|November 16, 2018
Patents and drug insurance: Clash of the Titans?Charles Phelps, Guruprasad Madhavan
Cost Effectiveness and Resource Allocation : C/E|November 21, 2018
Resource allocation in decision support frameworksCharles Phelps, Guruprasad Madhavan
Nature|January 13, 2017
Compare voting systems to improve themGuruprasad Madhavan, Charles Phelps, Rino Rappuoli
Vaccine|December 27, 2016
Beyond cost-effectiveness: Using systems analysis for infectious disease preparednessCharles Phelps, Guruprasad Madhavan, Rino Rappuoli, et al.
Vaccine|May 30, 2015
Bridging the gap: need for a data repository to support vaccine prioritization effortsGuruprasad Madhavan, Charles Phelps, Kinpritma Sangha, et al.
The Milbank Quarterly|March 21, 2016
Strategic Planning in Population Health and Public Health Practice: A Call to Action for Higher EducationCharles Phelps, Guruprasad Madhavan, Rino Rappuoli, et al.
Journal of Clinical Microbiology|January 5, 2002
Comparison of two culture methods for detection of tobramycin-resistant gram-negative organisms in the sputum of patients with cystic fibrosisJill M Van Dalfsen, Jenny R Stapp, Charles Phelps, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 6, 2014
A priority-setting aid for new vaccine candidatesCharles Phelps, Guruprasad Madhavan, Kinpritma Sangha, et al.
Cancer Chemotherapy and Pharmacology|August 8, 2014
Impact of cytochrome P450 3A4 inducer and inhibitor on the pharmacokinetics of trabectedin in patients with advanced malignancies: open-label, multicenter studiesJean-Pascal Machiels, Arthur Staddon, Catherine Herremans, et al.
Leukemia & Lymphoma|January 14, 2016
Quisinostat, bortezomib, and dexamethasone combination therapy for relapsed multiple myelomaPhilippe Moreau, Thierry Facon, Cyrille Touzeau, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Science Translational Medicine|November 16, 2018
Patents and drug insurance: Clash of the Titans?Charles Phelps, Guruprasad Madhavan
Cost Effectiveness and Resource Allocation : C/E|November 21, 2018
Resource allocation in decision support frameworksCharles Phelps, Guruprasad Madhavan
Nature|January 13, 2017
Compare voting systems to improve themGuruprasad Madhavan, Charles Phelps, Rino Rappuoli
Vaccine|December 27, 2016
Beyond cost-effectiveness: Using systems analysis for infectious disease preparednessCharles Phelps, Guruprasad Madhavan, Rino Rappuoli, et al.
Vaccine|May 30, 2015
Bridging the gap: need for a data repository to support vaccine prioritization effortsGuruprasad Madhavan, Charles Phelps, Kinpritma Sangha, et al.
The Milbank Quarterly|March 21, 2016
Strategic Planning in Population Health and Public Health Practice: A Call to Action for Higher EducationCharles Phelps, Guruprasad Madhavan, Rino Rappuoli, et al.
Journal of Clinical Microbiology|January 5, 2002
Comparison of two culture methods for detection of tobramycin-resistant gram-negative organisms in the sputum of patients with cystic fibrosisJill M Van Dalfsen, Jenny R Stapp, Charles Phelps, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 6, 2014
A priority-setting aid for new vaccine candidatesCharles Phelps, Guruprasad Madhavan, Kinpritma Sangha, et al.
Cancer Chemotherapy and Pharmacology|August 8, 2014
Impact of cytochrome P450 3A4 inducer and inhibitor on the pharmacokinetics of trabectedin in patients with advanced malignancies: open-label, multicenter studiesJean-Pascal Machiels, Arthur Staddon, Catherine Herremans, et al.
Leukemia & Lymphoma|January 14, 2016
Quisinostat, bortezomib, and dexamethasone combination therapy for relapsed multiple myelomaPhilippe Moreau, Thierry Facon, Cyrille Touzeau, et al.
Pageof 2